Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults

Posaconazole is a potent broad-spectrum triazole antifungal. Little is known about the prevalence and risk factors for low plasma posaconazole concentrations (PPCs). We retrospectively reviewed all adult patients whose PPCs were measured after at least 5 days of treatment between April 2006 and July...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lebeaux, David, Lanternier, Fanny, Elie, Caroline, Suarez, Felipe, Buzyn, Agnès, Viard, Jean-Paul, Bougnoux, Marie-Elisabeth, Lecuit, Marc, Jullien, Vincent, Lortholary, Olivier
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2009
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2786318/
https://ncbi.nlm.nih.gov/pubmed/19752284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00939-09
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars